Jeffrey Runge

Insider Reports History

Location
C/O Pharmathene, Inc., One Park Place, Suite 450, Annapolis, MD
Signature
/s/ Jeffrey Runge
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeffrey Runge:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aditxt, Inc. Director Options (right to buy) 470 Nov 8, 2023 Direct

Insider Reports Filed by Jeffrey Runge

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ADTX Aditxt, Inc. Nov 8, 2023 1 $0 4 Nov 13, 2023 Director
ADTX Aditxt, Inc. Sep 29, 2021 1 $0 4 Oct 1, 2021 Director
ADTX Aditx Therapeutics, Inc. Jun 1, 2021 6 $29.3K 4 Jun 2, 2021 Director